Advertisement
Advertisement
RDY
Dr. Reddy's Laboratories Limited - ADR
11.76
USDSponsored
+0.03
+0.26%
Jul 29, 15:59 UTC -4
Closed
Pre-Market
11.81
+0.05
+0.47%
RDY Earnings Reports
Positive Surprise Ratio
RDY beat 23 of 42 last estimates.
55%
Next Report
Date of Next Report
Oct 22, 2026
Estimate for Q2 27 (Revenue/ EPS)
$85.83B
/$9.66
Implied change from Q1 27 (Revenue/ EPS)
+5.96%
/+81.24%
Implied change from Q2 26 (Revenue/ EPS)
-2.78%
/-40.26%
Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue
On Jul 22, 2026, RDY reported earnings of 5.33 USD per share (EPS) for Q1 27, missing the estimate of 9.03 USD, resulting in a -40.99% surprise. Revenue reached 81.00 billion, compared to an expected 83.23 billion, with a -2.69% difference. The market reacted with a -9.39% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 3 analysts forecast an EPS of 9.66 USD, with revenue projected to reach 85.83 billion USD, implying an increase of 81.24% EPS, and increase of 5.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bausch Health Companies Inc
Report Date
Jul 29, 2026 For Q2 26
Estimate
$1.04
Actual
$1.26
Surprise
+20.34%
Teva Pharmaceutical Industries Limited - ADR
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.31
Actual
$0.02
Surprise
-93.67%
FAQ
What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Dr. Reddy's Laboratories Limited - ADR reported EPS of $5.33, missing estimates by -40.99%, and revenue of $81.00B, -2.69% below expectations.
How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q1 2027 earnings?
The stock price moved down -9.39%, changed from $12.56 before the earnings release to $11.38 the day after.
When is Dr. Reddy's Laboratories Limited - ADR expected to report next?
The next earning report is scheduled for Oct 22, 2026.
What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?
Based on 3
analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $9.66 and revenue of $85.83B for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement